Meet Our Founder
Angèle Nalbandian, Ph.D.
Principal at MedPub Scientific Communications, LLC
Meet Angèle, our Founder and Principal at MedPub Scientific Communications. After graduating with a Master’s in Biotechnology and Doctorate in the Biomedical Sciences from Georgetown University in Washington DC, Angele ventured to Harvard School of Public Health and Harvard Medical School to continue her pursuit of science. As a dynamic science and grant writer, Angèle plays a pivotal role in advancing research by crafting compelling proposals that secure funding for innovative projects. With over 50 publications (both original and review articles), she possesses a deep understanding of scientific concepts, regulatory requirements, and funding agency priorities, allowing them to translate complex ideas into clear, persuasive narratives. This type of work requires a blend of technical expertise, strategic thinking, and strong storytelling to align research objectives with funding opportunities.
Throughout her career, Angèle has navigated multiple roles, successfully securing over $250 Million in grant funding including NIH grants, private foundation grants, for both academia and biotechnology/pharmaceutical entities. Beyond her career achievements, Angele has served as an editorial board member for Musculoskeletal Regeneration and Archives of Medical Science to name a few.
Angèle’s journey is not just about professional milestones; it is a reflection of her dedication and commitment to the scientific community and medicine. By staying updated on emerging scientific trends and grant policies, she helps biotechnology and pharmaceutical companies as well as researchers and organizations navigate the competitive funding landscape, ultimately driving scientific progress and discovery.

Our Grant Writing
Dream Team
20+ Years of Expertise
We bring decades of experience in securing SBIR/STTR, NIH, and other R&D grants.
Comprehensive Services
From strategy development to writing, editing, and submission, we handle it all.
Industry Specialists
We work with startups and established companies, ensuring your proposal meets funders’ expectations.
Regulatory Non-Clinical Expertise
We craft compelling grants aligned with early drug development and lifecycle management (LCM) strategies.